Dynamic Technology Lab Private LTD Adma Biologics, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $37,198 - $49,419	10,720 Added 50.44%	31,975 $114,000
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $29,771 - $40,267	9,542 Added 81.47%	21,255 $78,000
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $35,256 - $45,329	11,713 New	11,713 $39,000
Q2 2021 Aug 13, 2021	SELL	$1.51 - $2.07 $48,292 - $66,202	-31,982 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.67 - $2.95 $19,071 - $33,689	11,420 Added 55.54%	31,982 $56,000
Q4 2020 Feb 11, 2021	SELL	$1.8 - $2.56 $40,005 - $56,896	-22,225 Reduced 51.94%	20,562 $40,000
Q3 2020 Nov 13, 2020	BUY	$2.04 - $3.74 $10,644 - $19,515	5,218 Added 13.89%	42,787 $102,000
Q2 2020 Aug 14, 2020	BUY	$2.42 - $3.29 $90,916 - $123,602	37,569 New	37,569 $110,000

326

190M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.31B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.